ZA903895B - New porous pharmaceutical form and its preparation - Google Patents
New porous pharmaceutical form and its preparationInfo
- Publication number
- ZA903895B ZA903895B ZA903895A ZA903895A ZA903895B ZA 903895 B ZA903895 B ZA 903895B ZA 903895 A ZA903895 A ZA 903895A ZA 903895 A ZA903895 A ZA 903895A ZA 903895 B ZA903895 B ZA 903895B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- preparation
- pharmaceutical form
- new porous
- date nov
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Filtering Materials (AREA)
- Materials For Medical Uses (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8906781A FR2647343B1 (fr) | 1989-05-24 | 1989-05-24 | Nouvelle forme pharmaceutique poreuse et sa preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA903895B true ZA903895B (en) | 1991-03-27 |
Family
ID=9381955
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA903895A ZA903895B (en) | 1989-05-24 | 1990-05-21 | New porous pharmaceutical form and its preparation |
ZA903978A ZA903978B (en) | 1989-05-24 | 1990-05-23 | New compositions based on inipramine |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA903978A ZA903978B (en) | 1989-05-24 | 1990-05-23 | New compositions based on inipramine |
Country Status (24)
Country | Link |
---|---|
US (1) | US5244881A (de) |
EP (2) | EP0399903B1 (de) |
JP (1) | JP2948271B2 (de) |
KR (1) | KR0163423B1 (de) |
AT (2) | ATE83663T1 (de) |
AU (2) | AU623779B2 (de) |
CA (2) | CA2017360A1 (de) |
DD (1) | DD297915A5 (de) |
DE (2) | DE69005359T2 (de) |
DK (2) | DK0399903T3 (de) |
ES (2) | ES2062437T3 (de) |
FI (1) | FI103712B1 (de) |
FR (1) | FR2647343B1 (de) |
GR (1) | GR3006655T3 (de) |
IE (2) | IE64370B1 (de) |
IL (2) | IL94459A (de) |
NO (1) | NO180517C (de) |
NZ (2) | NZ233766A (de) |
PL (1) | PL285327A1 (de) |
PT (2) | PT94139B (de) |
TW (1) | TW257672B (de) |
WO (1) | WO1990014089A1 (de) |
YU (1) | YU100790A (de) |
ZA (2) | ZA903895B (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE196426T1 (de) * | 1991-06-21 | 2000-10-15 | Takeda Chemical Industries Ltd | Zyklodextrin-zusammensetzung enthaltend fumagillol-derivate |
HU219349B (en) | 1991-12-24 | 2001-03-28 | Yamanouchi Pharma Co Ltd | Intrabuccally disintegrating preparation and production thereof |
GB9318880D0 (en) * | 1993-09-11 | 1993-10-27 | Smithkline Beecham Plc | Pharmaceutical composition |
CA2190598A1 (en) * | 1994-05-27 | 1995-12-07 | Lawrence John Penkler | Pharmaceutical composition |
ES2318869T3 (es) * | 1997-02-20 | 2009-05-01 | Massachusetts Institute Of Technology | Forma de dosificacion que presenta propiedades de dispersion rapida, metodos de uso y procedimiento para su fabricacion. |
BE1011251A3 (fr) | 1997-07-03 | 1999-06-01 | Ucb Sa | Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine. |
TW527195B (en) | 1997-10-09 | 2003-04-11 | Ssp Co Ltd | Fast-soluble solid pharmaceutical combinations |
WO1999039694A2 (en) * | 1998-02-05 | 1999-08-12 | Novartis Ag | Compositions containing organic compounds |
IT1304190B1 (it) * | 1998-12-18 | 2001-03-08 | Euphar Group Srl | Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche |
US6287603B1 (en) * | 1999-09-16 | 2001-09-11 | Nestec S.A. | Cyclodextrin flavor delivery systems |
NZ534039A (en) | 2002-01-15 | 2006-08-31 | Ucb Farchim S | Formulations of pharmaceutical compositions for oral administration |
US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
PL373780A1 (en) | 2002-02-25 | 2005-09-19 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
DE10239531A1 (de) | 2002-08-23 | 2004-03-04 | Gulbins, Erich, Prof. Dr. | Prophylaxe und Therapie von Infektionserkrankungen |
DE10248314A1 (de) * | 2002-10-16 | 2004-04-29 | Dr. Suwelack Skin & Health Care Ag | Verwendung von Formkörpern zur äußeren Anwendung |
FR2876910B1 (fr) * | 2004-10-21 | 2007-04-13 | Pierre Fabre Medicament Sa | Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction |
WO2006104610A2 (en) | 2005-02-24 | 2006-10-05 | Diffusion Pharmaceuticals Llc | Trans carotenoids, their synthesis, formulation and uses |
DE102005041860A1 (de) * | 2005-09-02 | 2007-03-08 | Schering Ag | Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen |
AU2008246305B2 (en) | 2007-04-13 | 2013-03-21 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease |
JP2009091309A (ja) * | 2007-10-10 | 2009-04-30 | Japan Organo Co Ltd | バコパモニエラエキスを含有する組成物およびその製造方法ならびに飲食品 |
WO2009058399A1 (en) | 2007-10-31 | 2009-05-07 | Diffusion Pharmaceuticals Llc | A new class of therapeutics that enhance small molecule diffusion |
ES2564056T3 (es) * | 2008-09-05 | 2016-03-17 | Johnson & Johnson Consumer Inc. | Método para hacer pastillas de cetirizina |
EP3539542B1 (de) | 2009-06-22 | 2023-04-19 | Diffusion Pharmaceuticals LLC | Verteilungsverbesserte verbindungen und ihre verwendung mit einem thrombolyticum |
AU2011262361A1 (en) | 2010-06-02 | 2013-01-10 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
BR112013005987A2 (pt) * | 2010-09-13 | 2019-09-24 | Bev Rx Inc | composição farmacêutica estável em água, composição farmacêutica oral na forma líquida, processo para preparar uma composição farmacêutica estável em água, kit e composição de bebida de reidratação |
RU2609198C1 (ru) * | 2016-01-25 | 2017-01-30 | Закрытое Акционерное Общество "БИОКОМ" | Твердая лекарственная форма имипрамина немедленного высвобождения и способ ее получения |
US11185523B2 (en) | 2016-03-24 | 2021-11-30 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5443570B2 (de) * | 1972-10-27 | 1979-12-20 | ||
IE45770B1 (en) * | 1976-10-06 | 1982-11-17 | Wyeth John & Brother Ltd | Pharmaceutical dosage forms |
US4165382A (en) * | 1977-10-17 | 1979-08-21 | Jose Pozuelo | Method of pharmacologically treating schizophrenia with alpha-methyl-para-tyrosine |
US4284555A (en) * | 1979-04-27 | 1981-08-18 | Schering Corporation | 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
US4349472A (en) * | 1979-04-27 | 1982-09-14 | Schering Corporation | (S)-8(1-Adamantanecarbonyloxy)-7-chloro-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
US4477378A (en) * | 1980-02-05 | 1984-10-16 | Schering Corp. | Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
US4758566A (en) * | 1984-11-27 | 1988-07-19 | Dainippon Pharmaceutical Co., Ltd. | 2-(1-piperazinyl)-4-substituted phenylquinoline derivatives, processes for the preparation thereof, and pharmaceutical composition containing the same |
GB8506792D0 (en) * | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
-
1989
- 1989-05-24 FR FR8906781A patent/FR2647343B1/fr not_active Expired - Fee Related
-
1990
- 1990-05-21 ZA ZA903895A patent/ZA903895B/xx unknown
- 1990-05-21 IE IE182190A patent/IE64370B1/en not_active IP Right Cessation
- 1990-05-21 IL IL9445990A patent/IL94459A/en not_active IP Right Cessation
- 1990-05-21 IL IL94460A patent/IL94460A0/xx unknown
- 1990-05-22 ES ES90401369T patent/ES2062437T3/es not_active Expired - Lifetime
- 1990-05-22 DE DE90401369T patent/DE69005359T2/de not_active Expired - Lifetime
- 1990-05-22 ES ES90401370T patent/ES2054289T3/es not_active Expired - Lifetime
- 1990-05-22 US US07/776,344 patent/US5244881A/en not_active Expired - Fee Related
- 1990-05-22 EP EP90401370A patent/EP0399903B1/de not_active Expired - Lifetime
- 1990-05-22 DK DK90401370.3T patent/DK0399903T3/da active
- 1990-05-22 KR KR1019900007369A patent/KR0163423B1/ko not_active IP Right Cessation
- 1990-05-22 DK DK90401369.5T patent/DK0399902T3/da active
- 1990-05-22 DE DE9090401370T patent/DE69000641T2/de not_active Expired - Fee Related
- 1990-05-22 NZ NZ233766A patent/NZ233766A/xx unknown
- 1990-05-22 AT AT90401370T patent/ATE83663T1/de not_active IP Right Cessation
- 1990-05-22 AU AU55828/90A patent/AU623779B2/en not_active Ceased
- 1990-05-22 EP EP90401369A patent/EP0399902B1/de not_active Expired - Lifetime
- 1990-05-22 AT AT90401369T patent/ATE98867T1/de not_active IP Right Cessation
- 1990-05-22 AU AU57433/90A patent/AU631888B2/en not_active Ceased
- 1990-05-22 WO PCT/FR1990/000359 patent/WO1990014089A1/fr unknown
- 1990-05-23 IE IE186290A patent/IE63317B1/en not_active IP Right Cessation
- 1990-05-23 PT PT94139A patent/PT94139B/pt not_active IP Right Cessation
- 1990-05-23 CA CA002017360A patent/CA2017360A1/fr not_active Abandoned
- 1990-05-23 NZ NZ233784A patent/NZ233784A/xx unknown
- 1990-05-23 CA CA002017355A patent/CA2017355A1/fr not_active Abandoned
- 1990-05-23 FI FI902553A patent/FI103712B1/fi not_active IP Right Cessation
- 1990-05-23 ZA ZA903978A patent/ZA903978B/xx unknown
- 1990-05-23 DD DD90340952A patent/DD297915A5/de not_active IP Right Cessation
- 1990-05-23 PT PT94138A patent/PT94138B/pt not_active IP Right Cessation
- 1990-05-23 NO NO902280A patent/NO180517C/no unknown
- 1990-05-23 YU YU01007/90A patent/YU100790A/xx unknown
- 1990-05-23 JP JP2131437A patent/JP2948271B2/ja not_active Expired - Lifetime
- 1990-05-24 PL PL28532790A patent/PL285327A1/xx unknown
- 1990-05-30 TW TW079104379A patent/TW257672B/zh active
-
1992
- 1992-12-24 GR GR920401770T patent/GR3006655T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA903895B (en) | New porous pharmaceutical form and its preparation | |
IL68230A0 (en) | Quaternary 6,11-dihydro-dibenzo(b,e)thiepine-11-n-alkyl-norscopine ethers,their preparation and pharmaceutical compositions containing them | |
ZA979220B (en) | New oxadiazoles, processes for their preparation and their use as pharmaceutical compositions. | |
SE9704546D0 (sv) | Novel compounds | |
MY101566A (en) | Pharmaceutical compositions. | |
SE9802937D0 (sv) | Novel compounds | |
NO913035D0 (no) | (2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav. | |
GB9013448D0 (en) | Pharmaceutical resorption-improved somatostatin compositions,their preparation and use | |
IL95046A0 (en) | Substituted 2-imidazolines and pharmaceutical compositions containing them | |
EP0619744A4 (de) | Nichtionische x-strahlen-kontrastmittel, zusammensetzungen und methoden. | |
AR008474A1 (es) | Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso | |
GB8918761D0 (en) | Substituted 4-azatricyclo(22.3.1.04.9)octacos-18-ene derivate,its preparation and pharmaceutical compositions containing it | |
GB8918760D0 (en) | Substituted 4-azatricyclo(22.3.1.04.9)octacos-18-ene derivate,its preparation and pharmaceutical compositions containing it | |
MX9200443A (es) | Hidrato de 6-ciclohexil-2'-o-metil-adenosina, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
BR9107189A (pt) | Tiangazol sua preparação, composições e sua itilização. | |
ZA926026B (en) | New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same. |